GI Symptoms Do Not Affect Enteral Nutrition Delivery in Patients With COVID-19
Researchers analyzed the relationship between GI symptoms and nutritional intake through enteral nutrition in patients critically ill with COVID-19.
Gastrointestinal Illnesses
PPIs Linked to Higher Risk for Infection, Decompensation in Cirrhosis
Researchers investigated the relationship between proton pump inhibitor exposure and infection, decompensation, and all-cause mortality in liver cirrhosis.
Ampicillin Resistance Common in Escherichia coli Isolates From Children With Diarrhea
Investigators assessed antimicrobial resistant profiles of Escherichia coli pathotypes detected via fecal swabs among children with diarrhea from Mozambique.
COPD and Future Functional Gastrointestinal Disorders
Is there an association between COPD and functional gastrointestinal disorders, including GERD, irritable bowel syndrome, and functional dyspepsia?
Prognostic Model Predicts Survival in Elderly With GI Diffuse Large B-Cell Lymphoma
A prognostic model based on clinical parameters has been developed and validated for predicting overall survival among elderly patients with EGI DLBCL.
Concomitant PPI and Advanced Therapy Linked to Worse Outcomes in IBD
A team of investigators evaluated the effects of concomitant use of PPIs and advanced therapy on health care resources in patients with IBD.
Oral Microbiome Therapy Sustains Clinical Cure for Recurrent C difficile
Presenting at DDW 2022, researchers evaluated data from the PRISM3 placebo-controlled trial and the PRISM-EXT open-label extension trial of CP101, an investigational microbiome therapeutic.
Travelers’ Diarrhea Significantly Increases Urinary Tract Infection Risk
Researchers assessed whether there is an association between urinary tract infection incidence and international travel.
Eradication of H pylori Infection Reduces Risk for Gastric Cancer
A team of researchers investigated the long-term effects of eliminating H pylori infection in patients at high risk for gastric cancer.
Voquezna Triple, Dual Pak Approved for H. Pylori Infection Treatment
The approval was based on data from a phase 3 study that compared Voquezna Triple and Dual Pak with lansoprazole plus amoxicillin and clarithromycin.
- Loading...
Loading...
Next post in GI Illness
Loading... 
Loading...